Applying For Grants
Translational and Clinical Research (TCR) Flagship Programme
The aim of the Translational and Clinical Research (TCR) Flagship programme is to establish Singapore as a leader in a number of strategic disease-oriented areas by supporting research that facilitates the translation of basic scientific advances into clinical applications through the integration, coordination and leverage of the full chain of research capabilities.
The programme seeks to integrate, coordinate and leverage research from basic science to clinical research, in the following identified five disease areas: Cancer, Cardiovascular/Metabolic Disorders, Neurosciences, Infectious diseases, and Eye diseases.
Moreover, this programme helps to build up a critical mass of excellent researchers in the five areas mentioned above. This will also position Singapore as a leader in scientific and medical research, in addition to improving the quality of clinical care. It will in turn attract more foreign patients to seek care in Singapore, and also attract biotech, medical devices and pharmaceutical companies to relocate here.
The TCR Flagship Programme is funded by the National Research Foundation (NRF) with a budget of S$25 million for each disease area over 5 years.
Researchers, clinicians and clinician scientists working in one of the above strategic areas are all applicable for this award. The proposed programme has to be integrative and demonstrate a strong collaborative nature. It also has to be scientifically competitive with the potential of being a leader in its field internationally. All applications will be evaluated by the TCR Flagship Review Committee comprising of local and international members. Short-listed applicants would have to submit a more detailed proposal for review by international experts before a final evaluation by the TCR Flagship Review Committee.
Since 2007, through 3 grant calls, all of the five TCR flagship programmes have been awarded to the following teams.